Subhash Krishnamoorthy, MD
Surgical Critical Care · New York, NYNPI 1851650329
Payments from drug & device makers
What this record shows
The money is spread across several categories — education (47.9%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. Intuitive Surgical accounts for 97.4% of it on its own, with 6 other manufacturers making up the rest. Reporting peaked in 2019 at $7,558 and has fallen 99.6% since, to $29 in 2025.
Across 47 payments — averaging $266.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$12K
- AstraZeneca$125
- W. L. Gore & Associates, Inc.$66
- Acell, Inc.$51
- Integra Lifesciences Corporation$29
- Boston Scientific$29
- plus $22 from 1 others
What the payments were for
- Travel & lodging$5,07140%
- Food & beverage$1,45212%
- Education$6,00048%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 41 | $12,201 |
| AstraZeneca | 1 | $125 |
| W. L. Gore & Associates, Inc. | 1 | $66 |
| Acell, Inc. | 1 | $51 |
| Integra Lifesciences Corporation | 1 | $29 |
| Boston Scientific | 1 | $29 |
| Johnson & Johnson | 1 | $22 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Da Vinci Surgical System$10,732
- DAVINCI XI$1,000
- CALQUENCE$125
How this compares
$12,523 in reported general payments places this provider in the 85th percentile of 118 surgical critical care providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone Hcl | 23 | $20 |
Paid to pharmacies, not to this prescriber.
Other surgical critical care in New York
- Matthew ChatoorNew York$27K
- Phillip BarieNew York$15K
- Erin FitzgeraldNew York$6K
- Natasha ColemanNew York$5K
- Beth HochmanNew York$4K
- Steven CohenNew York$3K
- Katherine FischkoffNew York$3K
- Asaf GaveNew York$2K
- Jian ShouNew York$1K
- Sanam AhmedNew York$1K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.